Interestingly, a recent study showed that metformin inhibits the formation of tumor spheroids by ovarian cancer cells through a mechanism involving an increased FOXO3 nuclear localization and a consequent inhibition of the expression of several stemness markers, including Nanog, Oct-4 and c-MYC [254]. The gene discussed is NANOG; the disease is ovarian carcinoma.